Over-prescription of short-acting β<sub>2</sub>-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study-Reference-Cited by-同舟云学术

Over-prescription of short-acting β₂-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Published:2022-06-20 Issue:3 Volume:60 Page:574-587
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Montero-Arias Felicia¹,Garcia Jose Carlos Herrera²,Gallego Manuel Pacheco³,Antila Martti Anton⁴,Schonffeldt Patricia⁵,Mattarucco Walter Javier⁶,Gallegos Luis Fernando Tejado⁷,Beekman Maarten J. H. I.⁸

Affiliation:

1. Servicio de Neumología, Hospital México, CCSS y Hospital Clínica Bíblica Santa Ana, San José, Costa Rica

2. Pulmonary Function Unit, Unidad de Funcion Pulmonar, Unidad de investigación Clínica de Puebla, UISP Unidad de Investigación y Salud de Puebla, Puebla, Mexico

3. Neumología, Unversidad Tecnológica de Pereira Y Fundación Universitaria Visión de las Américas. Respiremos S.A.S–Clinical Comfamiliar, Pereira, Colombia

4. Clinical Research/Allergy, Clínica de Alergia Martti Antila, São Paulo, Brazil

5. Especialista Médicina Interna y Enfermedades Respiratorias, Instituto Nacional del Tórax ITMS Telemedicina de Chile, Santiago, Chile

6. Neumonólogo, CEPROSS (Centro profesional San Salvador), Entre Rios, Argentina

7. Evidence Generation, AstraZeneca, Mexico City, Mexico

8. Respiratory & Immunology, AstraZeneca, The Hague, The Netherlands

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2022.2082305

Reference58 articles.

1. Global Asthma Network (GAN). The Global Asthma Report. Available from: http://www.globalasthmareport.org [accessed 22 March 2021]; 2018.

2. Asthma: epidemiology of disease control in Latin America – short review

3. Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?

4. Asthma in Latin America: a public heath challenge and research opportunity

5. Prevalence of asthma symptoms in Latin America: The international study of asthma and allergies in childhood (ISAAC)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Technology to Improve Adherence in Allergy/Immunology;The Journal of Allergy and Clinical Immunology: In Practice;2024-07

2. How to implement the anti-inflammatory reliever treatment proposed by the Global Initiative for Asthma in low- and middle-income countries;Exploration of Asthma & Allergy;2024-06-12

3. Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil;Jornal Brasileiro de Pneumologia;2024-01-17

4. Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach;Current Allergy and Asthma Reports;2023-11

5. Gaps in asthma diagnosis and treatment in low- and middle-income countries;Frontiers in Allergy;2023-10-23